Full-Time

Account Manager

Confirmed live in the last 24 hours

Schrödinger

Schrödinger

501-1,000 employees

Computational platform for drug discovery research

Enterprise Software
Biotechnology
Healthcare

Junior, Mid

United Kingdom

Category
Customer Success Management
Sales & Account Management
Requirements
  • Experience in account management, business development, or consulting in the chemical and/or pharmaceutical industries
  • Advanced degree in life sciences (knowledge of materials science or molecular modeling is a plus)
  • Some familiarity with computational chemistry software
  • Fluency in English
Responsibilities
  • Identify, qualify, and develop new business in relation to biotech, pharmaceuticals, and life science sectors
  • Manage and grow existing accounts
  • Collaborate with the EU+ team to develop business and marketing strategies to target specific customer segments
  • Produce timely and accurate business reports and revenue forecasts
  • Travel to customers and conferences

Schrödinger provides a computational platform that aids in the research efforts of biopharmaceutical companies, academic institutions, and government laboratories around the world. Their platform offers advanced computational tools that help in drug discovery and development across various therapeutic areas. Schrödinger's products work by utilizing sophisticated algorithms and simulations to predict how different compounds will interact, which can significantly speed up the research process. Unlike many competitors, Schrödinger not only licenses its software but also engages in collaborative drug discovery programs, allowing them to work closely with clients on specific projects. The company's goal is to enhance scientific research and innovation by providing powerful tools and resources that support the development of new therapies.

Company Stage

IPO

Total Funding

$362.7M

Headquarters

New York City, New York

Founded

1990

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Schrödinger's rapid identification of development candidates, such as SGR-1505, significantly accelerates the drug discovery process, offering a competitive advantage.
  • Recent investments from firms like Duality Advisers LP and Moody Aldrich Partners LLC indicate strong market confidence in Schrödinger's growth potential.
  • The company's expansion into new space in New York reflects its growth trajectory and commitment to scaling its operations.

What critics are saying

  • The high costs associated with expanding physical space and investing in new technologies could strain financial resources if not managed carefully.
  • The competitive nature of the drug discovery and computational chemistry sectors means Schrödinger must continuously innovate to maintain its edge.

What makes Schrödinger unique

  • Schrödinger's unique integration of physics-based computational methods with machine learning sets it apart in the drug discovery landscape.
  • The company's ability to triage billions of compounds and identify development candidates in a fraction of the typical time showcases its technological edge.
  • Schrödinger's commitment to ESG initiatives, as highlighted in their annual Corporate Sustainability report, adds a layer of corporate responsibility that differentiates it from many competitors.

Help us improve and share your feedback! Did you find this helpful?